OBI Pharma Announces First Patient Enrolled on SWOG Cancer Research Network s OBI-3424 Phase 1/2 Study Targeting AKR1C3 in T-ALL and T-LBL prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.